Welcome to LookChem.com Sign In|Join Free
  • or
5-Nitrovanillin, a member of the benzaldehyde class, is a derivative of vanillin with a nitro group substituted for the hydrogen atom ortho to the hydroxy group. This organic compound is known for its potential applications in various industries, particularly in the synthesis of compounds with antitumor properties.

6635-20-7

Post Buying Request

6635-20-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6635-20-7 Usage

Uses

Used in Pharmaceutical Industry:
5-Nitrovanillin is used as a reagent for the synthesis of feruloyl and caffeoyl compounds, which possess antitumor properties. These synthesized compounds can be further utilized in the development of novel therapeutic agents for cancer treatment, targeting various types of tumors and contributing to the advancement of cancer research and drug development.

Flammability and Explosibility

Nonflammable

Purification Methods

It forms yellow plates from AcOH and needles from EtOH [Slotta & Szyszke Chem Ber 68 184 1935]. With diazomethane, 5-nitro-3,4-dimethoxyacetophenone is formed [Brady & Manjunath J Chem Soc 125 1067 1924]. The methyl ether crystallises from EtOAc or AcOH, m 88o, 90-91o, and the phenylhydrazone has m 108-110o (from aqueous EtOH). [Finger & Schott J Prakt Chem [2] 115 288 1927.] The oxime has m 216o (from EtOH or AcOH), and the oxime acetate has m 147o (from aqueous EtOH) [Vogel Monatsh Chem 20 384 1899, Brady & Dunn J Chem Soc 107 1861 1915]. [Beilstein 8 III 2064.]

Check Digit Verification of cas no

The CAS Registry Mumber 6635-20-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,6,3 and 5 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6635-20:
(6*6)+(5*6)+(4*3)+(3*5)+(2*2)+(1*0)=97
97 % 10 = 7
So 6635-20-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H7NO5/c1-14-7-3-5(4-10)2-6(8(7)11)9(12)13/h2-4,11H,1H3

6635-20-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A14296)  5-Nitrovanillin, 97%   

  • 6635-20-7

  • 5g

  • 262.0CNY

  • Detail
  • Alfa Aesar

  • (A14296)  5-Nitrovanillin, 97%   

  • 6635-20-7

  • 25g

  • 589.0CNY

  • Detail
  • Alfa Aesar

  • (A14296)  5-Nitrovanillin, 97%   

  • 6635-20-7

  • 100g

  • 1886.0CNY

  • Detail

6635-20-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-nitrovanillin

1.2 Other means of identification

Product number -
Other names 5-Nitrovanillin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6635-20-7 SDS

6635-20-7Synthetic route

vanillin
121-33-5

vanillin

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With nitric acid In acetic acid Nitration;98%
With nitric acid; acetic acid at 20℃; regioselective reaction;97%
With zirconyl nitrate In acetone at 20℃; for 3h;94%
C8H8N2O5
51673-97-3

C8H8N2O5

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With C2H5NO2*C9H7NO*6H2O*Cl2Co; dihydrogen peroxide In methanol for 2h; Reflux;85%
vanillin
121-33-5

vanillin

A

6-nitrovanillin
2454-72-0

6-nitrovanillin

B

isonitrovanillin
6635-20-7

isonitrovanillin

C

2-nitrovanillin
2450-26-2

2-nitrovanillin

Conditions
ConditionsYield
With Nitrogen dioxide under 225.02 Torr; for 12h;A 6%
B 81%
C 10%
copper(II) bis(2-methoxy-6-nitroso-4-formylphenolato)

copper(II) bis(2-methoxy-6-nitroso-4-formylphenolato)

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With polymer-supported thiourea In acetone at 20℃; for 24h; Molecular sieve; Inert atmosphere;21%
5-formyl-2-hydroxy-3-methoxy-benzenesulfonic acid
859932-59-5

5-formyl-2-hydroxy-3-methoxy-benzenesulfonic acid

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With water; nitric acid
4-hydroxymethyl-2-methoxyphenol
498-00-0

4-hydroxymethyl-2-methoxyphenol

A

2-methoxy-4-nitrophenol
3251-56-7

2-methoxy-4-nitrophenol

B

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With sulfuric acid; nitric acid; cis-nitrous acid at 25℃; Product distribution; Mechanism;A 25 % Spectr.
B 50 % Spectr.
vanillin
121-33-5

vanillin

A

2-methoxy-4-nitrophenol
3251-56-7

2-methoxy-4-nitrophenol

B

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With sulfuric acid; nitric acid; cis-nitrous acid at 25℃; Product distribution; Mechanism;A 25 % Spectr.
B 70 % Spectr.
4-(hydroxymethyl)-2-methoxy-6-nitrophenol
37987-22-7

4-(hydroxymethyl)-2-methoxy-6-nitrophenol

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With sodium hydroxide; potassium hexacyanoferrate(III) In 2-methoxy-ethanol
nitric acid
7697-37-2

nitric acid

vanillin
121-33-5

vanillin

acetic acid
64-19-7

acetic acid

isonitrovanillin
6635-20-7

isonitrovanillin

diethyl ether
60-29-7

diethyl ether

cis-nitrous acid
7782-77-6

cis-nitrous acid

vanillin
121-33-5

vanillin

acetone
67-64-1

acetone

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
at 0℃; zeitlicher Verlauf der Reaktion;
vanillin
121-33-5

vanillin

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With nitric acid In acetic acid Nitration;98%
With nitric acid; acetic acid at 20℃; regioselective reaction;97%
With zirconyl nitrate In acetone at 20℃; for 3h;94%
C8H8N2O5
51673-97-3

C8H8N2O5

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With C2H5NO2*C9H7NO*6H2O*Cl2Co; dihydrogen peroxide In methanol for 2h; Reflux;85%
vanillin
121-33-5

vanillin

A

6-nitrovanillin
2454-72-0

6-nitrovanillin

B

isonitrovanillin
6635-20-7

isonitrovanillin

C

2-nitrovanillin
2450-26-2

2-nitrovanillin

Conditions
ConditionsYield
With Nitrogen dioxide under 225.02 Torr; for 12h;A 6%
B 81%
C 10%
copper(II) bis(2-methoxy-6-nitroso-4-formylphenolato)

copper(II) bis(2-methoxy-6-nitroso-4-formylphenolato)

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With polymer-supported thiourea In acetone at 20℃; for 24h; Molecular sieve; Inert atmosphere;21%
5-formyl-2-hydroxy-3-methoxy-benzenesulfonic acid
859932-59-5

5-formyl-2-hydroxy-3-methoxy-benzenesulfonic acid

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With water; nitric acid
4-hydroxymethyl-2-methoxyphenol
498-00-0

4-hydroxymethyl-2-methoxyphenol

A

2-methoxy-4-nitrophenol
3251-56-7

2-methoxy-4-nitrophenol

B

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With sulfuric acid; nitric acid; cis-nitrous acid at 25℃; Product distribution; Mechanism;A 25 % Spectr.
B 50 % Spectr.
vanillin
121-33-5

vanillin

A

2-methoxy-4-nitrophenol
3251-56-7

2-methoxy-4-nitrophenol

B

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With sulfuric acid; nitric acid; cis-nitrous acid at 25℃; Product distribution; Mechanism;A 25 % Spectr.
B 70 % Spectr.
4-(hydroxymethyl)-2-methoxy-6-nitrophenol
37987-22-7

4-(hydroxymethyl)-2-methoxy-6-nitrophenol

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With sodium hydroxide; potassium hexacyanoferrate(III) In 2-methoxy-ethanol
nitric acid
7697-37-2

nitric acid

vanillin
121-33-5

vanillin

acetic acid
64-19-7

acetic acid

isonitrovanillin
6635-20-7

isonitrovanillin

diethyl ether
60-29-7

diethyl ether

cis-nitrous acid
7782-77-6

cis-nitrous acid

vanillin
121-33-5

vanillin

acetone
67-64-1

acetone

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
at 0℃; zeitlicher Verlauf der Reaktion;
tetrachloromethane
56-23-5

tetrachloromethane

vanillin
121-33-5

vanillin

benzoyl nitrate

benzoyl nitrate

isonitrovanillin
6635-20-7

isonitrovanillin

diethyl ether
60-29-7

diethyl ether

vanillin
121-33-5

vanillin

concentrated , with nitros gases saturated nitric acid

concentrated , with nitros gases saturated nitric acid

isonitrovanillin
6635-20-7

isonitrovanillin

vanillin
121-33-5

vanillin

nitros gases

nitros gases

isonitrovanillin
6635-20-7

isonitrovanillin

nitric acid
7697-37-2

nitric acid

vanillin
121-33-5

vanillin

A

2-methoxy-4,6-dinitrophenol
4097-63-6

2-methoxy-4,6-dinitrophenol

B

isonitrovanillin
6635-20-7

isonitrovanillin

C

6,6'-dihydroxy-5,5'-dimethoxy-biphenyl-3,3'-dicarbaldehyde
2092-49-1

6,6'-dihydroxy-5,5'-dimethoxy-biphenyl-3,3'-dicarbaldehyde

Conditions
ConditionsYield
bei maessiger Waerme;
vanillin
121-33-5

vanillin

benzoyl nitrate

benzoyl nitrate

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With tetrachloromethane
5-formyl-2-hydroxy-3-methoxy-benzenesulfonic acid
859932-59-5

5-formyl-2-hydroxy-3-methoxy-benzenesulfonic acid

water
7732-18-5

water

nitric acid
7697-37-2

nitric acid

isonitrovanillin
6635-20-7

isonitrovanillin

3,4-dimethoxy-benzaldehyde
120-14-9

3,4-dimethoxy-benzaldehyde

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: nitric acid / acetic acid
2: aluminum (III) chloride; pyridine / chloroform / Reflux
View Scheme
5-nitroveratral
22027-96-9

5-nitroveratral

isonitrovanillin
6635-20-7

isonitrovanillin

Conditions
ConditionsYield
With pyridine; aluminum (III) chloride In chloroform Reflux;
isonitrovanillin
6635-20-7

isonitrovanillin

3,4-dihydroxy-5-nitrobenzaldehyde
116313-85-0

3,4-dihydroxy-5-nitrobenzaldehyde

Conditions
ConditionsYield
With hydrogen bromide; acetic acid In water at 110℃; for 39h;100%
With pyridine; aluminium trichloride In chloroform for 24h; ether cleavage; Heating;98%
With hydrogen bromide; acetic acid In water for 8h; Heating;96%
isonitrovanillin
6635-20-7

isonitrovanillin

4-(hydroxymethyl)-2-methoxy-6-nitrophenol
37987-22-7

4-(hydroxymethyl)-2-methoxy-6-nitrophenol

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 0 - 20℃; for 1h;100%
With sodium hydroxide; sodium tetrahydroborate
isonitrovanillin
6635-20-7

isonitrovanillin

C9H6F3NO7S
1021493-52-6

C9H6F3NO7S

Conditions
ConditionsYield
With pyridine; trifluoromethylsulfonic anhydride In dichloromethane at 0 - 20℃; for 2.5h; Inert atmosphere;99%
isonitrovanillin
6635-20-7

isonitrovanillin

2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio)propanehydrazide

2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio)propanehydrazide

N'-(4-hydroxy-3-methoxy-5-nitrobenzylidene)-2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin -8-ylthio)propanehydrazide

N'-(4-hydroxy-3-methoxy-5-nitrobenzylidene)-2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin -8-ylthio)propanehydrazide

Conditions
ConditionsYield
In ethanol for 2h; Reflux;98%
isonitrovanillin
6635-20-7

isonitrovanillin

cyanoacetic acid
372-09-8

cyanoacetic acid

2-cyano-3-(3-methoxy 4-hydroxy-5-nitrophenyl)acrylic acid

2-cyano-3-(3-methoxy 4-hydroxy-5-nitrophenyl)acrylic acid

Conditions
ConditionsYield
With piperidine; acetic acid In ethanol for 3h; Reflux;96.2%
isonitrovanillin
6635-20-7

isonitrovanillin

2-hydroxy-5-chloro-aniline
95-85-2

2-hydroxy-5-chloro-aniline

C14H11ClN2O5
1372174-37-2

C14H11ClN2O5

Conditions
ConditionsYield
In ethanol for 3h; Reflux;96%
isonitrovanillin
6635-20-7

isonitrovanillin

5-nitroveratral
22027-96-9

5-nitroveratral

Conditions
ConditionsYield
In tetrahydrofuran; diethyl ether Ambient temperature;95%
In methanol; diethyl ether for 96h;
isonitrovanillin
6635-20-7

isonitrovanillin

2-cyano-N,N-diethylacetamide
26391-06-0

2-cyano-N,N-diethylacetamide

(2E)-2-cyano-3-(3-methoxy-4-hydroxy-5-nitro-phenyl)-N,Ndiethylprop-2-enamide
857629-78-8

(2E)-2-cyano-3-(3-methoxy-4-hydroxy-5-nitro-phenyl)-N,Ndiethylprop-2-enamide

Conditions
ConditionsYield
With sodium hydroxide In methanol at 20℃; for 16h;95%
With sodium hydroxide In methanol for 16h;95%
ammonium acetate In ethanol Knoevenagel Condensation; Heating / reflux;70%
trifluoromethylsulfonic anhydride
358-23-6

trifluoromethylsulfonic anhydride

isonitrovanillin
6635-20-7

isonitrovanillin

C9H6F3NO7S
1021493-52-6

C9H6F3NO7S

Conditions
ConditionsYield
In dichloromethane at 0℃;95%
isonitrovanillin
6635-20-7

isonitrovanillin

2-cyano-N,N-diethylacetamide
26391-06-0

2-cyano-N,N-diethylacetamide

2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)prop-2-enamide
146698-91-1

2-cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)prop-2-enamide

Conditions
ConditionsYield
acetic acid; glycine In toluene for 12 - 15h; Knoevenagel Condensation; Heating / reflux;94.2%
isonitrovanillin
6635-20-7

isonitrovanillin

[5-(1-methyl-5-nitro-1H-imidazol-2-yl)-[1,3,4]thiadiazol-2-yl]-hydrazine
823200-60-8

[5-(1-methyl-5-nitro-1H-imidazol-2-yl)-[1,3,4]thiadiazol-2-yl]-hydrazine

C14H12N8O6S

C14H12N8O6S

Conditions
ConditionsYield
With hydrogenchloride In ethanol at 20℃; for 0.5h;93%
BARBITURIC ACID
67-52-7

BARBITURIC ACID

isonitrovanillin
6635-20-7

isonitrovanillin

malononitrile
109-77-3

malononitrile

7-amino-5-(4-hydroxy-3-methoxy-5-nitrophenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile

7-amino-5-(4-hydroxy-3-methoxy-5-nitrophenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile

Conditions
ConditionsYield
With choline chloride; thiourea; urea In water for 0.25h; Reflux;93%
isonitrovanillin
6635-20-7

isonitrovanillin

benzyl bromide
100-39-0

benzyl bromide

4-benzyloxy-3-methoxy-5-nitrobenzaldehyde
127027-58-1

4-benzyloxy-3-methoxy-5-nitrobenzaldehyde

Conditions
ConditionsYield
With potassium hydroxide; N-benzyl-N,N,N-triethylammonium chloride In dichloromethane at 20℃; for 24h; Alkylation;92%
malonic acid
141-82-2

malonic acid

isonitrovanillin
6635-20-7

isonitrovanillin

(2E)-3-(4-hydroxy-3-methoxy-5-nitrophenyl)acrylic acid
5438-42-6, 86981-09-1

(2E)-3-(4-hydroxy-3-methoxy-5-nitrophenyl)acrylic acid

Conditions
ConditionsYield
With piperidine; pyridine for 1h; Knoevenagel-Doebner reaction; Reflux;90%
With pyridine; aniline In toluene for 2h; Reflux;84.6%
at 20 - 100℃; for 148h; Condensation; elimination;75%
With piperidine; pyridine
isonitrovanillin
6635-20-7

isonitrovanillin

(E)-3-phenylacryloylhydrazide
3538-69-0

(E)-3-phenylacryloylhydrazide

(E)-N'-(4-hydroxy-3-methoxy-5-nitrobenzylidene)cinnamohydrazide

(E)-N'-(4-hydroxy-3-methoxy-5-nitrobenzylidene)cinnamohydrazide

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 1h; Reflux;90%
4-hydroxy-1-methyl-2(1H)-quinolone
1677-46-9

4-hydroxy-1-methyl-2(1H)-quinolone

isonitrovanillin
6635-20-7

isonitrovanillin

malononitrile
109-77-3

malononitrile

2-amino-4-(4-hydroxy-3-methoxy-5-nitrophenyl)-6-methyl-5-oxo-5,6-dihydro-4H-pyrano[3,2-c]quinoline-3-carbonitrile
1019060-09-3

2-amino-4-(4-hydroxy-3-methoxy-5-nitrophenyl)-6-methyl-5-oxo-5,6-dihydro-4H-pyrano[3,2-c]quinoline-3-carbonitrile

Conditions
ConditionsYield
With triethylamine In ethanol for 0.833333h; Heating;89%
isonitrovanillin
6635-20-7

isonitrovanillin

acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

urea
57-13-6

urea

methyl 4-(4-hydroxy-3-methoxy-5-nitrophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate

methyl 4-(4-hydroxy-3-methoxy-5-nitrophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Conditions
ConditionsYield
With strontium trifluoromethanesulfonate at 70℃; for 4h; Biginelli reaction;88%
isonitrovanillin
6635-20-7

isonitrovanillin

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

2-(4-hydroxy-5-methoxy-3-nitrophenyl)benzimidazole
134610-91-6

2-(4-hydroxy-5-methoxy-3-nitrophenyl)benzimidazole

Conditions
ConditionsYield
With boric acid In water at 20 - 40℃; for 0.0833333h;88%
In methanol; nitrobenzene
isonitrovanillin
6635-20-7

isonitrovanillin

1-bromomethyl-4-nitro-benzene
100-11-8

1-bromomethyl-4-nitro-benzene

3-methoxy-5-nitro-4-[(4-nitrophenyl)methoxy]benzaldehyde
1261736-55-3

3-methoxy-5-nitro-4-[(4-nitrophenyl)methoxy]benzaldehyde

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20 - 65℃; for 14h;88%
2-naphthohydrazide
39627-84-4

2-naphthohydrazide

isonitrovanillin
6635-20-7

isonitrovanillin

N'-[(1E)-4-hydroxy-3-methoxy-5-nitrobenzylidene]-2-naphthohydrazide
1394115-39-9

N'-[(1E)-4-hydroxy-3-methoxy-5-nitrobenzylidene]-2-naphthohydrazide

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 1h; Reflux;88%
isonitrovanillin
6635-20-7

isonitrovanillin

3-phenylpropanehydrazide
3538-68-9

3-phenylpropanehydrazide

N'-[(1E)-4-hydroxy-3-methoxy-5-nitrobenzylidene]-3-phenylpropanohydrazide
1394115-37-7

N'-[(1E)-4-hydroxy-3-methoxy-5-nitrobenzylidene]-3-phenylpropanohydrazide

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 1h; Reflux;88%
2,3-dihydrophthalazine-1,4-dione
1445-69-8

2,3-dihydrophthalazine-1,4-dione

isonitrovanillin
6635-20-7

isonitrovanillin

dimedone
126-81-8

dimedone

3,4‑dihydro‑3,3‑dimethyl‑13‑(4‑hydroxy‑3‑methoxy‑5‑nitrophenyl)‑2H‑indazolo[2,1‑b]phthalazine‑1,6,11(13H)‑trione

3,4‑dihydro‑3,3‑dimethyl‑13‑(4‑hydroxy‑3‑methoxy‑5‑nitrophenyl)‑2H‑indazolo[2,1‑b]phthalazine‑1,6,11(13H)‑trione

Conditions
ConditionsYield
With polymer-supported sulfonic acid (PSSA) In glycerol at 80℃; for 0.916667h;88%
With [4-(1,10-phenanthrolin-1-ium-1-yl)butane-1-sulfonate]3PW12O40 In water for 0.25h; Reflux; Green chemistry;80%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

isonitrovanillin
6635-20-7

isonitrovanillin

3,3'-[(4-hydroxy-3-methoxy-5-nitrophenyl)methylene]-bis(4-hydroxy-2H-1-benzopyran-2-one)

3,3'-[(4-hydroxy-3-methoxy-5-nitrophenyl)methylene]-bis(4-hydroxy-2H-1-benzopyran-2-one)

Conditions
ConditionsYield
With acetic acid for 5.5h; Heating;87%
With acetic acid for 5.5h; Heating;87%
In ethanol for 24h; Reflux;70%
isonitrovanillin
6635-20-7

isonitrovanillin

(2E)-3-(3,4-dimethoxy-5-nitrophenyl)acrylohydrazide
1394115-40-2

(2E)-3-(3,4-dimethoxy-5-nitrophenyl)acrylohydrazide

(2E)-3-(3,4-dimethoxy-5-nitrophenyl)-N'-[(1E)-(4-hydroxy-3-methoxy-5-nitrobenzylidene)]acrylohydrazide
1394115-32-2

(2E)-3-(3,4-dimethoxy-5-nitrophenyl)-N'-[(1E)-(4-hydroxy-3-methoxy-5-nitrobenzylidene)]acrylohydrazide

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 1h; Reflux;87%
isonitrovanillin
6635-20-7

isonitrovanillin

4-hydroxy-3-methoxy-5-nitrobenzonitrile
79743-73-0

4-hydroxy-3-methoxy-5-nitrobenzonitrile

Conditions
ConditionsYield
With hydroxylamine hydrochloride In dimethyl sulfoxide at 100℃; for 2h;87%
isonitrovanillin
6635-20-7

isonitrovanillin

(2E)-3-(3,4-dimethoxyphenyl)acrylohydrazide
88368-69-8

(2E)-3-(3,4-dimethoxyphenyl)acrylohydrazide

(2E)-3-(3,4-dimethoxyphenyl)-N'-[(1E)-(4-hydroxy-3-methoxy-5-nitrobenzylidene)]acrylohydrazide
1394115-34-4

(2E)-3-(3,4-dimethoxyphenyl)-N'-[(1E)-(4-hydroxy-3-methoxy-5-nitrobenzylidene)]acrylohydrazide

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water for 1h; Reflux;85%
isonitrovanillin
6635-20-7

isonitrovanillin

p-aminoiodobenzene
540-37-4

p-aminoiodobenzene

C14H11IN2O4

C14H11IN2O4

Conditions
ConditionsYield
With fly-ash:PTS In neat (no solvent) Microwave irradiation; Sealed tube;85%
isonitrovanillin
6635-20-7

isonitrovanillin

dimethyl sulfate
77-78-1

dimethyl sulfate

5-nitroveratral
22027-96-9

5-nitroveratral

Conditions
ConditionsYield
With sodium hydroxide; tetrabutylammomium bromide In dichloromethane; water for 24h;84%
With sodium hydroxide; benzyl tri-n-butylammonium bromide In dichloromethane for 24h;81%
With tetrabutylammomium bromide; sodium hydroxide In dichloromethane; water at 20℃; for 24h;76%
(i) aq. KOH, (ii) /BRN= 635994/; Multistep reaction;
(i) aq. KOH, (ii) /BRN= 635994/, xylene; Multistep reaction;

6635-20-7Relevant academic research and scientific papers

Method for producing entacapone

-

Paragraph 0041-0049, (2021/04/10)

The present invention relates to an entacapone production method, which comprises a nitration reaction, a de-methylation reaction and a condensation reaction. The nitration reaction is completed by glacial acetic acid, vanillin and 65% nitric acid within 3-5 hours; the de-methylation reaction is completed by reaction among nitrovanillin, dichloromethane, tetrabutyl ammonium bromide, anhydrous aluminum chloride and pyridine; and the condensation reaction is completed by reaction among isopropanol, 3,4-dihydroxyl-5-nitro benzaldehyde, N,N-diethyl cyanoacetamide and piperidine. The entacapone production method provided by the invention is high in yield, high in purity and stable in quality.

Synthesis and biological activity of fibrate-based acyl- and alkyl-phenoxyacetic methyl esters and 1,2-dihydroquinolines

Chamorro-Cevallos, Germán,Cruz-López, María C.,Delgado, Francisco,Fuentes-Benites, Aydeé,Gómez-García, Omar,Gardu?o-Siciliano, Leticia,González-Romero, Carlos,Hernández-Benitez, Roberto I.,Jiménez, Fabiola,López, Julio,Madrigal, Damián A.,Mendieta, Aarón,Pucheta, Abraham,Ramírez-Villalva, Alejandra,Ramón-Gallegos, Eva,Romero, Liseth,Rosales-Acosta, Blanca,Rugerio-Escalona, Catalina,Sequeda-Juárez, Alfonso,Tamariz, Joaquín,Vázquez, Miguel A.,Villa-Tanaca, Lourdes

, (2020/01/31)

A series of highly potent antihyperlipidemic agents constituted by a fibrate-based structure was recently reported by our group, whose synthesis started from isovanillin derivatives. In the interest of evaluating the bioisosteric effect of the vanillin-based isomers on their antihyperlipidemic activity, the present study focuses on the synthesis of 5-acyl-1-phenoxyacetic methyl esters 5a–c and their saturated side-chain 5-alkyl-1-phenoxyacetates 6a–c. Their strong in vivo effect was associated with the inhibition of HMG-CoA reductase. Since 1,2-dihydroquinolines inhibit this enzyme, a series of such heterocycles (9a–d) was prepared by our efficient regioselective, one-step, solvent-free method. Apart from showing hypolipidemic activity in vivo, some of the compounds displayed antifungal, antioxidant and cytotoxic activity in vitro. The binding mode of four compounds at the active site of HMGRh was examined with docking simulations, observing an interaction with most of the amino acids targeted by simvastatin.

Copper-mediated nitrosation: 2-nitrosophenolato complexes and their use in the synthesis of heterocycles

Nicholls, Alexander J.,Batsanov, Andrei S.,Baxendale, Ian R.

, (2019/11/28)

A simple protocol yielding ortho-substituted nitrosophenols from phenols is demonstrated, in the form of copper(II) bis(nitrosophenolato) complexes. The developed methodology was applied to a range of substrates, confirming the role of the copper in both the formation and protection of the challenging 1, 2-substitution pattern. Using polymer supported thiourea, the Cu could be stripped from the complexes and thus enabled the isolation or identification of the uncoordinated ligands and their decomposition products, in yields generally low in line with the intrinsic high reactivity of 2-nitrosophenols. The product complexes are useful intermediates as demonstrated in revisiting a formal [4 + 2] cycloaddition with dimethylacetylene dicarboxylate to synthesise bicyclic products in variable yields, revealing the product has a novel structure different from those previously reported in the literature.

Method for preparing 5-nitrovanillin through nitrifying vanillin by nitrogen dioxide

-

Paragraph 0011-0014, (2018/03/26)

The invention discloses a method for preparing 5-nitrovanillin through nitrifying vanillin by nitrogen dioxide. The method is characterized in that the vanillin and the nitrogen dioxide are stirred and reacted in the presence of a catalyst to obtain the 5-nitrovanillin. The nitrogen dioxide is used as a nitrifying reagent to substitute a nitric acid-acetic acid mixed acid nitrifying agent, so thecleanness of the above reaction is improved, and the environment pollution is reduced; the atom utilization rate and the atom economy property of the reaction are improved; reaction conditions are mild, the reaction is carried out in a nonacid medium, so waste acid treatment is avoided, the corrosion to a device is reduced, energy is saved, the emission is reduced, and the safety is high; and thecatalyst can be simply recovered, and can be reused multiple times.

a naked-eye colorimetric receptor for anions based on nitro group featuring with benzimidazole unit

Rahmawati,Purwono,Matsjeh

, p. 1933 - 1936 (2018/08/09)

A novel receptor based on nitro group featuring with benzimidazole unit (S2) was successfully synthesized and applied to the anion (CN–, F–and H2PO4–) recognition. The S2 changed its colour for light yellow to dark yellow on addition of the anions in DMSO solvent. The LOD and Kass values determined by UV-visible titration was 2.8 × 10–6 M and 1.2 (± 0.25) × 106 M–1 for CN– ion; 1.14 × 10–6 M and 2.5 (± 0.25) × 106 M–1 for F– ion; and 1.23 × 10–5 M and 6.25 (± 0.177) × 106 M–1 for H2PO4– ion, respectively.

Yttrium Nitrate mediated Nitration of Phenols at room temperature in Glacial Acetic acid

Mondal, Mohabul A,Mandal, Debashis,Mitra, Kanchan

, p. 39 - 43 (2017/01/24)

Rapid nitration of electron rich phenols using Y(NO 3) 3.6H 2O in glacial acetic acid at room temperature was observed with good yield. The method allows nitration of phenols without oxidation, and isolation of nitration product in a rapid and simple way. The described method is selective for phenols. [Figure not available: see fulltext.]

Synthesis and biological evaluation of cinnamido linked benzophenone hybrids as tubulin polymerization inhibitors and apoptosis inducing agents

Kamal, Ahmed,Reddy, Ch. Ratna,Vishnuvardhan,Mahesh,Lakshma Nayak,Prabhakar,Reddy, C. Suresh

supporting information, p. 2309 - 2314 (2014/05/20)

A new class of hybrid molecules containing cinnamide subunit linked to benzophenone as inhibitors of tubulin polymerization were synthesized and evaluated for their anticancer potential. These hybrids exhibit anticancer activity with IC50 values ranging from 0.06 to 16.3 μM. Compounds 4f and 4g possessing fluoro and trifluoromethyl on the cinnamido subunit showed significant cytotoxic activity with IC50 values 0.06 and 0.09 μM against HeLa cell line, respectively. These compounds showed cell cycle arrest at G2/M phase of the cell cycle and inhibited tubulin polymerization followed by activation of caspase-3 activity and apoptotic cell death. Further in vitro tubulin polymerization assay showed that the level of tubulin inhibition was comparable to that of 2a for the compounds 4f and 4g. Moreover, Hoechst 33258 staining and DNA fragmentation assay suggested that these compounds induce cell death by apoptosis. Overall, the current study demonstrates that the synthesis of benzophenone linked cinnamide subunit conjugates as promising anticancer agents with G2/M arrest and apoptotic-inducing ability via targeting tubulin.

Synthesis and antitumor activity of feruloyl and caffeoyl derivatives This paper is dedicated to Prof. Wei-xiao Hu for his lifelong commitment to mentoring graduate students

Chen, Hui-Zhen,Chen, You-Bao,Lv, Ya-Ping,Zeng, Fang,Zhang, Juan,Zhou, Yong-Lie,Li, Han-Bing,Chen, Li-Fei,Zhou, Bin-Jie,Gao, Jian-Rong,Xia, Chun-Nian

, p. 4367 - 4371 (2015/02/06)

We developed two efficient protocols for the synthesis of feruloyl and caffeoyl derivatives from commercial vanillin and veratraldehyde. Pharmacological activities were assessed against a panel of human cancer cell lines in vitro. Most synthesized compounds demonstrated attractive cytotoxicity. Several new compounds demonstrated significant antiproliferative and cytotoxic activities against HeLa and Bewo tumor cell lines. In particular, 5-nitro caffeic adamantyl ester showed broad spectrum of tumor inhibition in 10 cell lines, and reduced tumor weight by 36.7% in vivo when administered at a dose of 40 mg kg-1.

Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases

Nitsche, Christoph,Steuer, Christian,Klein, Christian D.

experimental part, p. 7318 - 7337 (2012/01/05)

The 3-aryl-2-cyanoacrylamide scaffold was designed as core pharmacophore for inhibitors of the Dengue and West Nile virus serine proteases (NS2B-NS3). A total of 86 analogs was prepared to study the structure-activity relationships in detail. Thereby, it turned out that the electron density of the aryl moiety and the central double bond have a crucial influence on the activity of the compounds, whereas the influence of substituents of the amide residue is less relevant. The para-hydroxy substituted analog was found to be the most potent inhibitor in this series with a Ki-value of 35.7 μM at the Dengue and 44.6 μM at the West Nile virus protease. The aprotinin competition assay demonstrates a direct interaction of the inhibitor molecule with active centre of the Dengue virus protease. The target selectivity was studied in a counterscreen with thrombin and found to be 2.8:1 in favor of DEN protease and 2.3:1 in favor of WNV protease, respectively.

Discovery of a long-acting, peripherally selective inhibitor of catechol- O -methyltransferase

Kiss, László E.,Ferreira, Humberto S.,Torr?o, Leonel,Bonifácio, Maria Jo?o,Palma, P. Nuno,Soares-Da-Silva, Patrício,Learmonth, David A.

supporting information; experimental part, p. 3396 - 3411 (2010/09/05)

Novel nitrocatechol-substituted heterocycles were designed and evaluated for their ability to inhibit catechol-O-methyltransferase (COMT). Replacement of the pyrazole core of the initial hit 4 with a 1,2,4-oxadiazole ring resulted in a series of compounds endowed with longer duration of COMT inhibition. Incorporation of a pyridine N-oxide residue at position 3 of the 1,2,4-oxadiazole ring led to analogue 37f, which was found to possess activity comparable to entacapone and lower toxicity in comparison to tolcapone. Lead structure 37f was systematically modified in order to improve selectivity and duration of COMT inhibition as well as to minimize toxicity. Oxadiazole 37d (2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4, 6-dimethylpyridine 1-oxide (BIA 9-1067)) was identified as a long-acting, purely peripheral inhibitor, which is currently under clinical evaluation as an adjunct to l-Dopa therapy of Parkinson's disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6635-20-7